GO:0032909 regulation of transforming growth factor beta2 production: Cytokine Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032909 describes any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2 (TGF-beta2), a secreted cytokine with broad roles in fibrosis, immunity, and development.
• TGF-beta2 production is regulated at multiple levels, including transcriptional control, post-translational modification of regulators such as ISG15 and CREB1, and extracellular processing of the latent cytokine.
• Dysregulated TGF-beta2 production is implicated in liver fibrosis, cigarette smoke-induced lung inflammation, kidney obstruction injury, and skin fibroblast growth control.
• Key genes and proteins involved include TGFB2, ISG15, CREB1, FGF23, and TGFBR signaling components, which can be studied using CRISPR knockout, knock-in, and overexpression models.
• CRISPR-based cell models (KO, point mutation, knock-in, overexpression) enable causal dissection of regulatory nodes controlling TGF-beta2 production.
• Understanding GO:0032909 supports therapeutic strategies targeting fibrosis, inflammatory lung disease, and immune tolerance.
Description
GO:0032909, regulation of transforming growth factor beta2 production, is a biological process Gene Ontology term that encompasses any mechanism controlling the frequency, rate, or extent of production of transforming growth factor-beta2 (TGF-beta2). TGF-beta2 is a secreted cytokine belonging to the TGF-beta superfamily, and its production is tightly regulated because inappropriate levels contribute to fibrosis, inflammation, and immune dysregulation. Researchers study this term to understand how cells adjust TGF-beta2 output in response to injury, infection, or metabolic cues, and to identify druggable nodes for intervention. The QuickGO definition emphasizes modulation of production, which can occur at transcriptional, post-transcriptional, translational, or post-translational levels. Experimental evidence shows that TGF-beta2 production is controlled by factors such as ISG15, CREB1, and fibroblast growth factor 23 (FGF23), linking this process to liver fibrosis and mineral metabolism. In cigarette smoke-induced lung injury, TGF-beta2 production is elevated and contributes to inflammation and tissue damage. Thus, GO:0032909 represents a convergence point for environmental, immune, and metabolic signals that shape TGF-beta2 availability.
regulation of transforming growth factor beta2 production At A Glance
| GO ID | GO:0032909 |
|---|---|
| GO term | regulation of transforming growth factor beta2 production |
| Ontology | biological_process |
| Synonym | regulation of TGF-B2 production; regulation of TGFB2 production; regulation of transforming growth factor-beta2 production |
| Definition | Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2. |
| Major function | Controls the amount of TGF-beta2 cytokine available for secretion and downstream signaling. |
| Related diseases | Liver fibrosis, lung inflammation, kidney injury, skin fibrosis |
| Key regulators | ISG15, CREB1, FGF23, TGFBR signaling |
| Research methods | CRISPR KO/knock-in, RNA-seq, proteomics, ELISA, imaging |
What Is GO:0032909?
In my own words, GO:0032909 refers to any cellular process that adjusts how much transforming growth factor-beta2 is made, whether by changing the rate of transcription, the efficiency of translation, the stability of the protein, or the processing of its precursor. It does not describe the downstream signaling of TGF-beta2 itself, but rather the upstream control of its production. This regulation can be positive or negative and operates in diverse cell types, including hepatic stellate cells, lung epithelial cells, and fibroblasts.
Why Is regulation of transforming growth factor beta2 production Important in Cell Biology?
GO:0032909 is important because TGF-beta2 is a potent cytokine whose production must be precisely controlled to avoid pathological fibrosis, chronic inflammation, and immune imbalance. In liver fibrosis, ISG15 deficiency in hepatic stellate cells promotes TGF-beta2-induced fibrosis by counteracting CREB1 ISGylation, directly linking a regulatory modification to disease progression. In the lung, cigarette smoke increases TGF-beta2 production, driving inflammation and injury. In the kidney, urinary tract obstruction leads to TGF-beta2-mediated fibrosis. In the skin, TGF-beta2 regulates fibroblast growth, affecting wound healing and fibrotic disorders. Therefore, understanding how TGF-beta2 production is regulated offers opportunities for therapeutic intervention in multiple organ systems.
• TGF-beta2 production is a key node in liver fibrosis, where ISG15 and CREB1 ISGylation control its levels.
• Cigarette smoke-induced lung inflammation and injury involve elevated TGF-beta2 production.
• Urinary tract obstruction triggers TGF-beta2-mediated kidney fibrosis.
• TGF-beta2 regulates skin fibroblast growth, impacting wound healing and fibrotic skin diseases.
• TGF-beta2 production is linked to fetal-maternal immune tolerance, with implications for pregnancy complications.
• FGF23 production is controlled by TGF-beta2, connecting this process to mineral metabolism.
• Probiotic supplementation in ulcerative colitis affects immunity-related gene expression, potentially including TGF-beta2.
• Recombinant TGF-beta2 production and structural analysis provide tools for studying its regulation.
• CRISPR screens can identify novel regulators of TGF-beta2 production.
• Targeting TGF-beta2 production may reduce fibrosis and inflammation in multiple diseases.
What Happens During regulation of transforming growth factor beta2 production?
Transcriptional control of TGFB2
In simple terms: The cell decides how much TGF-beta2 mRNA to make.
Transcription of the TGFB2 gene is modulated by transcription factors and signaling pathways in response to injury or inflammation. In hepatic stellate cells, CREB1 is a key transcription factor whose ISGylation status affects TGF-beta2 production, linking post-translational modifications to transcriptional output. Cigarette smoke exposure induces transcriptional upregulation of TGFB2 in lung cells, contributing to inflammation.
Post-transcriptional and post-translational regulation
In simple terms: After mRNA is made, the cell can still adjust how much protein is produced or how stable it is.
ISG15 deficiency in hepatic stellate cells promotes TGF-beta2-induced liver fibrosis by counteracting CREB1 ISGylation, demonstrating that post-translational modification of regulators controls TGF-beta2 production. This regulation can affect mRNA stability, translation efficiency, or protein processing.
Extracellular processing and secretion
In simple terms: TGF-beta2 is made as a precursor that must be processed and released from the cell.
TGF-beta2 is synthesized as a latent precursor that undergoes proteolytic processing and secretion. Recombinant production and structural analysis of human TGF-beta2 have revealed conformational details important for its maturation. The regulation of production includes steps that control the amount of mature cytokine available for release.
Feedback and cross-regulation with other factors
In simple terms: TGF-beta2 production is influenced by other signals and can feed back on itself.
TGF-beta2 controls the production of fibroblast growth factor 23 (FGF23), indicating cross-regulation between cytokine production pathways. In pregnancy, TGF-beta1 regulates fetal-maternal immune tolerance, and TGF-beta2 may play related roles. Probiotic supplementation in ulcerative colitis alters immunity-related gene expression, potentially affecting TGF-beta2 production.
Key Genes Involved in GO:0032909 regulation of transforming growth factor beta2 production
The following genes and proteins are experimentally implicated in the regulation of TGF-beta2 production or its downstream biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB2 | Encodes transforming growth factor beta2 | Central to GO:0032909; target for KO and overexpression |
| ISG15 | Modulates CREB1 ISGylation | Deficiency promotes TGF-beta2-induced liver fibrosis |
| CREB1 | Transcription factor regulating TGFB2 | ISGylation status affects TGF-beta2 production |
| FGF23 | Production controlled by TGF-beta2 | Links TGF-beta2 to mineral metabolism |
| TGFBR1 | TGF-beta receptor type 1 | Mediates downstream signaling of TGF-beta2 |
| TGFBR2 | TGF-beta receptor type 2 | Mediates downstream signaling of TGF-beta2 |
| SMAD2 | Canonical TGF-beta signaling effector | Transduces TGF-beta2 signals |
| SMAD3 | Canonical TGF-beta signaling effector | Transduces TGF-beta2 signals |
| SMAD4 | Common SMAD cofactor | Required for TGF-beta signaling |
| JUN | AP-1 transcription factor | Potential regulator of TGFB2 transcription |
| FOS | AP-1 transcription factor | Potential regulator of TGFB2 transcription |
| NFKB1 | Inflammatory transcription factor | May regulate TGFB2 in inflammation |
| STAT3 | Signal transducer and activator of transcription | Linked to fibrosis and TGF-beta2 |
| MAPK1 | Mitogen-activated protein kinase | Signaling node affecting TGF-beta2 production |
| MAPK3 | Mitogen-activated protein kinase | Signaling node affecting TGF-beta2 production |
| AKT1 | Serine/threonine kinase | May modulate TGF-beta2 production |
| MTOR | mTOR kinase | Potential regulator of translation of TGFB2 |
How Is regulation of transforming growth factor beta2 production Regulated?
Regulation of TGF-beta2 production is controlled by a network of signaling pathways and post-translational modifiers. ISG15 deficiency in hepatic stellate cells promotes TGF-beta2-induced liver fibrosis by counteracting CREB1 ISGylation, indicating that ISG15 and CREB1 ISGylation are critical regulators. Cigarette smoke exposure upregulates TGF-beta2 production in lung cells, likely through inflammatory signaling pathways. TGF-beta2 itself controls FGF23 production, suggesting feedback or cross-regulation. In pregnancy, TGF-beta1 regulates fetal-maternal immune tolerance, and similar mechanisms may apply to TGF-beta2. Probiotic supplementation in ulcerative colitis alters immunity-related gene expression, which may include TGF-beta2. These examples highlight that regulation occurs at transcriptional, post-translational, and extracellular processing levels.
regulation of transforming growth factor beta2 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ISG15 | Liver fibrosis | Hepatic stellate cell KO and overexpression |
| TGFB2 | Lung inflammation | Lung epithelial cell KO and knock-in |
| TGFB2 | Kidney fibrosis | Renal tubular cell overexpression |
| TGFB2 | Skin fibrosis | Dermal fibroblast KO |
| CREB1 | Liver fibrosis | Point mutation of ISGylation sites |
Liver fibrosis
ISG15 deficiency in hepatic stellate cells promotes TGF-beta2-induced liver fibrosis by counteracting CREB1 ISGylation. This identifies the ISG15-CREB1-TGF-beta2 axis as a potential therapeutic target for liver fibrosis.
Lung inflammation and injury
Cigarette smoke-induced lung inflammation and injury involve elevated TGF-beta2 production. Targeting TGF-beta2 production may reduce smoke-related lung damage.
Kidney fibrosis
Urinary tract obstruction leads to TGF-beta2-mediated kidney fibrosis. Regulation of TGF-beta2 production is therefore relevant to obstructive nephropathy.
Skin fibrosis and wound healing
TGF-beta2 regulates skin fibroblast growth, affecting wound healing and fibrotic skin disorders. Modulating its production could influence skin repair.
From regulation of transforming growth factor beta2 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ISG15 regulate TGF-beta2 production? | ISG15 knockout hepatic stellate cells |
| Does CREB1 ISGylation affect TGFB2 transcription? | CREB1 point mutant knock-in cells |
| Does cigarette smoke increase TGF-beta2 production? | Lung epithelial cell overexpression and KO |
| Does TGF-beta2 control FGF23 production? | TGFB2 knockout osteoblast-like cells |
| What is the role of TGF-beta2 in skin fibroblast growth? | TGFB2 knockout dermal fibroblasts |
| Can probiotics modulate TGF-beta2 production? | Mouse colitis models with probiotic supplementation |
How to Study the regulation of transforming growth factor beta2 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR KO | Loss of gene function | Identify regulators of TGF-beta2 production |
| CRISPR knock-in | Precise point mutations | Study ISGylation sites on CREB1 |
| Overexpression | Gain of function | Model TGF-beta2 overproduction |
| RNA-seq | Transcriptome changes | Map regulatory networks |
| Proteomics | Protein abundance and modifications | Detect ISGylation and other PTMs |
| ELISA | Secreted TGF-beta2 levels | Quantify production |
| Imaging | Localization and secretion | Track TGF-beta2 in cells |
CRISPR knockout and knock-in
CRISPR knockout of candidate regulators such as ISG15 or CREB1 can reveal their role in TGF-beta2 production. Knock-in of point mutations, such as ISGylation sites, allows precise dissection of post-translational control.
Overexpression and tagged knock-in
Overexpression of TGFB2 or its regulators can model pathological overproduction. Tagged knock-in of TGFB2 enables tracking of protein localization and secretion.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify global changes in gene expression and protein levels upon manipulation of regulatory nodes. These methods help map the regulatory network controlling TGF-beta2 production.
ELISA and imaging
ELISA quantifies secreted TGF-beta2 protein levels, while imaging can visualize its production and localization in cells. These are standard readouts for functional studies.
How CRISPR Can Be Used to Study GO:0032909 regulation of transforming growth factor beta2 production
Knockout
CRISPR knockout of ISG15 in hepatic stellate cells promotes TGF-beta2-induced liver fibrosis, demonstrating the utility of KO models to study regulation of TGF-beta2 production. Knockout of TGFB2 itself can confirm its role in downstream biology.
Point Mutation
Point mutation of ISGylation sites on CREB1 can reveal how ISG15 counteracts CREB1 ISGylation to control TGF-beta2 production. Such models are essential for dissecting post-translational regulation.
Knock-in
Knock-in of tagged TGFB2 allows tracking of its production and secretion in live cells. This approach can be combined with disease-relevant mutations.
Overexpression
Overexpression of TGFB2 in lung epithelial cells mimics cigarette smoke-induced TGF-beta2 production and inflammation. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports regulation of transforming growth factor beta2 production Research
Researchers studying regulation of transforming growth factor beta2 production-related genes often need to determine whether a candidate gene is causally involved in controlling TGF-beta2 levels. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to accelerate this research, from knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for regulation of transforming growth factor beta2 production research.
Frequently Asked Questions About regulation of transforming growth factor beta2 production
What is GO:0032909?
GO:0032909 is the Gene Ontology term for regulation of transforming growth factor beta2 production, describing any process that modulates the frequency, rate, or extent of TGF-beta2 production.
What genes are involved in regulation of TGF-beta2 production?
Key genes include TGFB2, ISG15, CREB1, and FGF23, among others.
How is TGF-beta2 production regulated?
It is regulated at transcriptional, post-transcriptional, and post-translational levels, including ISGylation of CREB1 by ISG15.
What diseases are associated with TGF-beta2 production?
Liver fibrosis, lung inflammation, kidney fibrosis, and skin fibrosis are associated with dysregulated TGF-beta2 production.
What is the role of ISG15 in TGF-beta2 production?
ISG15 deficiency promotes TGF-beta2-induced liver fibrosis by counteracting CREB1 ISGylation.
How can CRISPR be used to study TGF-beta2 production?
CRISPR knockout, knock-in, point mutation, and overexpression models can dissect the function of regulators in TGF-beta2 production.
What cell models are suitable for studying TGF-beta2 production?
Hepatic stellate cells, lung epithelial cells, renal tubular cells, and dermal fibroblasts are commonly used.
Does cigarette smoke affect TGF-beta2 production?
Yes, cigarette smoke induces TGF-beta2 production, contributing to lung inflammation and injury.
What is the link between TGF-beta2 and FGF23?
TGF-beta2 controls the production of FGF23, linking cytokine regulation to mineral metabolism.
How can I model TGF-beta2 overproduction?
Overexpression of TGFB2 in relevant cell types, such as lung epithelial cells, can model overproduction.
Conclusion
GO:0032909, regulation of transforming growth factor beta2 production, is a critical biological process with broad implications for fibrosis, inflammation, and immune regulation. Key regulators such as ISG15, CREB1, and FGF23 have been identified, and their dysfunction contributes to diseases including liver fibrosis and lung injury. CRISPR-based cell models provide powerful tools to dissect these regulatory mechanisms and identify therapeutic targets. EDITGENE offers comprehensive services to support such research, from knockout to overexpression and screening.
References
- 1. Yuan Y et al.. 2026. ISG15 deficiency in hepatic stellate cells promotes TGFβ2-induced liver fibrosis by counteracting CREB1 ISGylation.. Gut 75(6):1186-1200 PMID: 40819890
- 2. Ko HK et al.. 2023. The role of transforming growth factor-β2 in cigarette smoke-induced lung inflammation and injury.. Life Sci 320:121539 PMID: 36870385
- 3. Wu Y et al.. 2022. Probiotics (Lactobacillus plantarum HNU082) Supplementation Relieves Ulcerative Colitis by Affecting Intestinal Barrier Functions, Immunity-Related Gene Expression, Gut Microbiota, and Metabolic Pathways in Mice.. Microbiol Spectr 10(6):e0165122 PMID: 36321893
- 4. Feger M et al.. 2017. The production of fibroblast growth factor 23 is controlled by TGF-β2.. Sci Rep 7(1):4982 PMID: 28694529
- 5. Yang D et al.. 2021. Role of Transforming Growth Factor-β1 in Regulating Fetal-Maternal Immune Tolerance in Normal and Pathological Pregnancy.. Front Immunol 12:689181 PMID: 34531852
- 6. Klahr S. 2001. Urinary tract obstruction.. Semin Nephrol 21(2):133-45 PMID: 11245776
- 7. Del Amo-Maestro L et al.. 2019. Recombinant production, purification, crystallization, and structure analysis of human transforming growth factor β2 in a new conformation.. Sci Rep 9(1):8660 PMID: 31209258
- 8. Takehara K. 2000. Growth regulation of skin fibroblasts.. J Dermatol Sci 24 Suppl 1:S70-7 PMID: 11137399
